IRIS
GAMBA, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.078
AS - Asia 2.660
EU - Europa 2.147
SA - Sud America 328
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 76
OC - Oceania 6
Totale 9.381
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.938
CN - Cina 1.450
SG - Singapore 567
IE - Irlanda 445
UA - Ucraina 323
FI - Finlandia 259
HK - Hong Kong 234
BR - Brasile 226
DE - Germania 215
RU - Federazione Russa 213
IT - Italia 184
VN - Vietnam 170
GB - Regno Unito 136
SE - Svezia 122
FR - Francia 121
CA - Canada 66
IN - India 50
BD - Bangladesh 44
ZA - Sudafrica 42
AR - Argentina 36
PL - Polonia 35
IQ - Iraq 29
NL - Olanda 21
MX - Messico 20
BE - Belgio 19
JP - Giappone 16
CO - Colombia 15
EC - Ecuador 15
ID - Indonesia 15
IR - Iran 15
PK - Pakistan 12
VE - Venezuela 12
CR - Costa Rica 11
ES - Italia 11
MU - Mauritius 10
PR - Porto Rico 10
HN - Honduras 7
MA - Marocco 7
PE - Perù 7
CL - Cile 6
KE - Kenya 6
PY - Paraguay 6
SA - Arabia Saudita 6
TR - Turchia 6
TT - Trinidad e Tobago 6
AU - Australia 5
CZ - Repubblica Ceca 5
EG - Egitto 5
GT - Guatemala 5
LT - Lituania 5
PH - Filippine 5
SV - El Salvador 5
AT - Austria 4
BH - Bahrain 4
CH - Svizzera 4
OM - Oman 4
UZ - Uzbekistan 4
AL - Albania 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
GP - Guadalupe 3
GR - Grecia 3
JO - Giordania 3
LB - Libano 3
NI - Nicaragua 3
RO - Romania 3
SC - Seychelles 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DM - Dominica 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
NG - Nigeria 1
NP - Nepal 1
Totale 9.301
Salva come PNG Salva come JPEG
Città #
San Jose 553
Dublin 442
Chandler 431
Jacksonville 407
Ashburn 346
Nanjing 322
Singapore 306
Beijing 237
Hong Kong 228
Council Bluffs 206
Dallas 176
Boardman 148
Nanchang 117
Shenyang 92
Lawrence 89
Princeton 89
Changsha 88
Hebei 86
Wilmington 85
Los Angeles 82
Lauterbourg 79
Jiaxing 75
Helsinki 72
Ho Chi Minh City 61
Medford 61
Ann Arbor 59
Tianjin 58
Hangzhou 47
Moscow 39
New York 39
Hanoi 37
Buffalo 35
Woodbridge 35
Johannesburg 33
Milan 30
Munich 28
São Paulo 26
Santa Clara 25
Shanghai 25
Des Moines 22
Orem 22
Brussels 19
Houston 19
Warsaw 19
Chicago 18
Brooklyn 17
Redondo Beach 17
San Francisco 17
Verona 17
Seattle 16
Turku 16
Frankfurt am Main 15
Kunming 15
Montreal 15
Jinan 14
Radomsko 14
Tokyo 14
Toronto 14
Baghdad 13
Manchester 13
Rome 13
Amsterdam 12
Atlanta 12
Chennai 12
Poplar 12
Taizhou 12
Denver 11
London 11
Mexico City 11
Norwalk 11
Boston 10
Ningbo 10
Phoenix 10
Dearborn 9
Dhaka 9
Fairfield 9
Guangzhou 9
Leawood 9
Rio de Janeiro 9
San José 9
Stockholm 9
Zhengzhou 9
Mumbai 8
Fuzhou 7
Haiphong 7
Auburn Hills 6
Bologna 6
Da Nang 6
Guayaquil 6
Hải Dương 6
Naples 6
North Bergen 6
Quito 6
The Dalles 6
Biên Hòa 5
Columbus 5
Curitiba 5
Falkenstein 5
Falls Church 5
Jeddah 5
Totale 6.074
Salva come PNG Salva come JPEG
Nome #
Coagulation-factor deficiencies and abnormal bleeding in Noonan’s syndrome 176
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 158
Caratteristiche dell'emartro ed evoluzione in artropatia nelle coagulopatie congenite: osservazione su 145 casi afferenti al centro emofilia di Pavia 151
Screening dei difetti dell'emostasi con Platelet Function Analyzer (PFA-100) in donne con meno-metrorragia 149
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 143
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 142
Acquired von Willebrand syndrome and monoclonal gammopathy: clinical characterization and recovery to infusion of VWF-containing concentrates 141
Abnormalities in thrombin-antithrombin pathway in primary systemic amyloidosis. 141
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 136
Atherosclerosis, vascular damage, thrombotic risk factors and congenital bleeding disorders 134
An unconventional case of scurvy. 133
Mitral valve prolapse and prothrombotic risk factors in children and adolescents with migraine with aura and other idiopathic headaches 131
Clotting alterations in primary systemic amyloidosis. 129
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 129
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 128
L'artropatia e l'emartro ricorrente nelle coagulopatie congenite: l'influenza del trattamento. 128
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 128
Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. 126
Acquired von Willebrand syndrome in inflammatory bowel disease 126
Cardiovascular disease, hyperhomocysteinemia and atherothrombotic risk factors in psoriatic patients 125
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins. 125
Bleeding disorders in children with reccurent tonsillitis and prolonged aPTT 124
Long-term evaluation of synovectomy and synoviorthesis on the evolution of joint damage: what's happened after 30 years of follow up? 123
Platelet-independent defect in hemostasis associated with sirolimus use 123
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy. 119
La valutazione della qualità della vita e della artropatia nel paziente emofilico adulto. 118
Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study. 117
Castleman's disease with coagulation defect. A case report. 117
Renal diseases in haemophilic patients: pathogenesis and clinical management. 114
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. 113
Efficacy and safety of high doses of FEIBA for major surgery in a patient with haemophilia A and high titre inhibitor 112
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 112
Valutazione dell'artropatia in soggetti affetti da emofilia. 112
The behaviour of physiologic and acquired anticoagulants in patients with hyperhomocysteinemia and thrombotic complications 110
Defective anticoagulation system in patients with previous myocardial infarction and residual angina 109
In vitro and in vivo effects of desmopressin on platelet function 109
Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) 107
Patterns of bleeding,comorbidities, and clinical courses in acquired hemophilia A (AHA) and in acquired von Willebrand disease (AVWD): Experience from a single hemophiliaentre in Pavia 106
Homocysteine, vitamin b12 and folic acid levels in psoriasi patients and correlation with disease severity. 106
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 105
L'artropatia e l'emartro nelle coagulopatie congenite: l'influenza del trattamento 105
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 104
Liver damage and homocysteine plasma levels in haemophilia 103
Vascular damage, prothrombotic risk factor and trombosis in patients with inherited bleeding disorders 102
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study 102
Influenza del polimorfismo C677T del gene della MTHFR sui livelli di omocisteina plasmatici e sul rischio trombotico 101
Performance in sports of children and adolescents with hereditary bleeding disorders 101
Clotting alterations in primary systemic amyloidosis 100
THROMBOPHILIC SCREENING IN TURNER SYNDROME. 99
Platelet function after in vivo and in vitro treatment with thrombolytic agents 99
Homocysteine plasma levels and vascular damage in congenital clotting factor deficiencies 99
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 98
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 98
Thrombotic markers and mitral valve prolapse in migraine with and without aura at childhood onset 97
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 97
Malattia di von Willebrand acquisita in 2 pazienti con malattia infiammatoria cronica intestinale 97
Prevalenza di trombosi arteriose e venose in presenza delle mutazioni G20210A del gene della protrombina e R506Q del gene del FV (Leiden) 96
Treatment of bleeding episodes in acquired haemophilia with activated prothrombin complex concentrate: what is the optimal therapy? 94
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study. 94
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 94
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease. 93
Impaired expression of dipeptidylaminopeptidase IV (DAPN)/CD26 in lymphocytes of hemophiliacs 93
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. 93
Desmopressin and platelets: In vitro and in vivo studies 92
Bleeding tendency of unknown origin and protein Z levels. 92
Von Willebrand factor/factor VIII behaviour and haemorrhagic manifestations in patients with neurofibromatosis type I 88
Plasma exchange and immunosuppressive therapy in a case of mild haemophilia A with inhibitors and a life-threatening lower limb haemorrhage. 88
Imbalance of oxidant and antioxidant mechanism in ischaemic heart diseases 86
Normalization of homocysteine plasma levels improves the physiological anticoagulation in patients with thromboembolic diseases 84
Haemarthroses and arthropathy in mild/moderate haemophilia: data collected from a single Haemophilia Centre, Pavia, Italy 83
Prolonged aPTT occasionally detected in children before adenotonsillectomy and bleeding disorders 83
Preoperative bleeding risk assessment with ISTH-BAT and laboratory tests in patients undergoing elective surgery: A prospective cohort study 81
Treatment and progression of liver damage in HCV+ haemophiliacs: over 15 years follow up 81
Expression of dipeptidylaminopeptidase IV-CD26 in circulating lymphocytes of homophilic subjects 79
Risk factors of thrombosis in poorly controlled inflammatory bowel diseases: benefecial effect of LMW heparin as adjuvant therapy 78
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study 78
Long-term follow up in Acquired Hemophilia A: clinical courses and outcomes observed in a single Hemophilia Centre 77
Homocysteine and liver steatosis in HCV infected haemophiliacs 77
Modalità di diagnosi e caratteristiche cliniche della M di von Willebrand acquisita 75
Two years prophylaxis with FEIBA and inhibitors levels in a high responder haemophilic patient 74
HEPARIN INFUSION FACILITATES PLATELETS ACTIVABILITY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION WHO HAVE UNDERGONE THROMBOLYTIC THERAPY 74
Interobserver reliability of ultrasound assessment of haemophilic arthropathy: Radiologist vs. non-radiologist 73
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 73
Menometrorrhagia in adolescents: is it the first expression of congenital defects of hemostasis 71
Platelet aggregation in platelet rich plasma and whole blood in 18 patients affected by agnogenic myeloid metaplasia 71
Thromboembolic disease and thrombotic risk factors: The effect of treating Hìhyperhomocysteinemia on physiological anticoagulation 71
Ruolo patogenetico delle alterazioni emocoagulative nell'insorgenza di s poliabortiva e di patologie ostetriche 70
Haemostasis and low molecular weight heparin (LMWH) therapy in chronic inflammatory bowel diseases (IBD) not responsive to conventional therapy. 68
Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants 62
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. 58
Totale 9.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.532
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022384 0 0 0 0 3 10 13 20 33 13 50 242
2022/20231.270 146 85 2 111 148 137 0 62 508 17 35 19
2023/2024363 67 51 18 31 48 81 0 34 5 10 14 4
2024/20251.070 15 97 25 33 21 47 21 78 269 29 139 296
2025/20262.981 233 202 295 347 322 125 706 123 224 191 157 56
2026/2027693 44 140 174 330 5 0 0 0 0 0 0 0
Totale 9.381